Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus erythematosus (SLE) have been revealed, and have not disappointed ...

The fervor generated by the annual debate to identify the best active golfer without a victory in a major has abated for the year, but the same consideration co ...